UK5099 Inhibits the NLRP3 Inflammasome Independently of its Long‐Established Target Mitochondrial Pyruvate Carrier
Abstract Targeting NLRP3 inflammasome has been recognized as a promising therapeutic strategy for the treatment of numerous common diseases. UK5099, a long‐established inhibitor of mitochondrial pyruvate carrier (MPC), is previously found to inhibit macrophage inflammatory responses independent of M...
Guardat en:
| Autors principals: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2024-09-01
|
| Col·lecció: | Advanced Science |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/advs.202307224 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
